Shenghan Chen is a professor at the Human Aging Research Institute and School of Life Science at Nanchang University. She received her MD degree from Hubei Medical College in China in 1984 and also an MSc Degree from the same school in 1989. She has engaged in the practice of medicine and medical research for 12 years. In 2000, she joined Lerner Research Institute of Cleveland Clinic in the United States to study molecular biology and genetics on cardiovascular diseases, especially hypertension and heart failure. In 2016, she started to work at the Human Aging Research Institute of Nanchang University in China. Her research field is cardiovascular aging and focused on the cardiovascular senescence related genes, signaling pathways and underlying molecular mechanisms. She has been an Editorial Board Member of BioEssays, Referee of Aging Cell and served on National Grant Review Panels and Study Sections (NSFC). She received the Cleveland Clinic Innovator Award.